Foxconn invests US$30 million in Robocore to expand into elderly care robotics market
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
For patients with resectable early-stage gastric and gastroesophageal junction cancers
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
Subscribe To Our Newsletter & Stay Updated